Synonyms: GSK3772701 | GSK701 | MMV1582367
Compound class:
Synthetic organic
Comment: MMV367 is an antimalarial clinical candidate, selected from a new class of pyrrolidinamide-containing compounds identified from a phenotypic screen. The chemical structure was first disclosed during the 265th National Meeting of the American Chemical Society (Boston, 2018) [4] and is one of the structures claimed in patent WO2019145360A1 [2].
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
Guide to Malaria Pharmacology Comments |
MMV367 is a fast-acting antimalarial with potential as an artemisinin replacement as part of a combination therapy for uncomplicated malaria [3]. Potential Target/Mechanism Of Action: MMV367 is reported to target P. falciparum acyl-CoA synthetase (PfACS10; PF3D7_0525100) [1]. |